乐普医疗：10月24日召开董事会会议

Core Viewpoint - Lepu Medical announced the convening of its 18th meeting of the 6th Board of Directors on October 24, 2025, to review the full report for the third quarter of 2025 [1] Company Summary - For the first half of 2025, Lepu Medical's revenue composition is as follows: medical devices account for 52.72%, pharmaceuticals for 33.16%, and medical services and health management for 14.11% [1] - As of the report, Lepu Medical has a market capitalization of 32.2 billion yuan [1] Industry Summary - The Chinese innovative drug sector has seen significant overseas licensing sales, totaling 80 billion USD this year [1] - There is a contrast in the biopharmaceutical secondary market's activity compared to the primary market, where fundraising has encountered challenges [1]